The test included 73 patients with recurrent disease and 142 patients with no recurrence within 5 years of surgery. Researchers developed a gene signature, and in tests, the signature identified high-risk patients with a hazard ration of 2.62.
Related Articles on Colorectal Cancer:
Study: Poor Men More Likely to Die of Colorectal Cancer
Screening Baby Boomers for Hepatitis C During a Routine Colon Cancer Screening
Current, Former Smokers Face Elevated Colorectal Cancer Risk
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
